Publication: Establishing apomorphine treatment in Thailand: understanding the challenges and opportunities of Parkinson’s disease management in developing countries
Issued Date
2020-06-02
Resource Type
ISSN
17448360
14737175
14737175
Other identifier(s)
2-s2.0-85086775938
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Expert Review of Neurotherapeutics. Vol.20, No.6 (2020), 523-537
Suggested Citation
Roongroj Bhidayasiri, Onanong Phokaewvarangkul, Karn Sakdisornchai, Kamolwan Boonpang, K. Ray Chaudhuri, Jan Parsons, Praween Lolekha, Parnsiri Chairangsaris, Prachaya Srivanitchapoom, Sharon Benedierks, Pattamon Panyakaew, Thanatat Boonmongkol, Yuwadee Thongchuam, Nitinan Kantachadvanich, Saisamorn Phumphid, Andrew H. Evans, Akravudh Viriyavejakul, Apichart Pisarnpong, Teus van Laar, Priya Jagota Establishing apomorphine treatment in Thailand: understanding the challenges and opportunities of Parkinson’s disease management in developing countries. Expert Review of Neurotherapeutics. Vol.20, No.6 (2020), 523-537. doi:10.1080/14737175.2020.1770598 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/58134
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Establishing apomorphine treatment in Thailand: understanding the challenges and opportunities of Parkinson’s disease management in developing countries
Author(s)
Roongroj Bhidayasiri
Onanong Phokaewvarangkul
Karn Sakdisornchai
Kamolwan Boonpang
K. Ray Chaudhuri
Jan Parsons
Praween Lolekha
Parnsiri Chairangsaris
Prachaya Srivanitchapoom
Sharon Benedierks
Pattamon Panyakaew
Thanatat Boonmongkol
Yuwadee Thongchuam
Nitinan Kantachadvanich
Saisamorn Phumphid
Andrew H. Evans
Akravudh Viriyavejakul
Apichart Pisarnpong
Teus van Laar
Priya Jagota
Onanong Phokaewvarangkul
Karn Sakdisornchai
Kamolwan Boonpang
K. Ray Chaudhuri
Jan Parsons
Praween Lolekha
Parnsiri Chairangsaris
Prachaya Srivanitchapoom
Sharon Benedierks
Pattamon Panyakaew
Thanatat Boonmongkol
Yuwadee Thongchuam
Nitinan Kantachadvanich
Saisamorn Phumphid
Andrew H. Evans
Akravudh Viriyavejakul
Apichart Pisarnpong
Teus van Laar
Priya Jagota
Other Contributor(s)
Thammasat University Hospital
King Chulalongkorn Memorial Hospital, Faculty of Medicine Chulalongkorn University
King's College Hospital
The Walton Centre
Faculty of Medicine, Siriraj Hospital, Mahidol University
University of Groningen
Royal Melbourne Hospital
Prasat Neurological Institute
Stada Pharmaceuticals
Phramongkutklao Hospital
King Chulalongkorn Memorial Hospital, Faculty of Medicine Chulalongkorn University
King's College Hospital
The Walton Centre
Faculty of Medicine, Siriraj Hospital, Mahidol University
University of Groningen
Royal Melbourne Hospital
Prasat Neurological Institute
Stada Pharmaceuticals
Phramongkutklao Hospital
Abstract
© 2020, © 2020 Informa UK Limited, trading as Taylor & Francis Group. Introduction: The increasing global burden of Parkinson’s disease (PD) poses a particular challenge for developing countries, such as Thailand, when delivering care to a geographically diverse populace with limited resources, often compounded by a lack of expertise in the use of certain PD medications, such as device-aided therapies (DAT). Areas covered: A panel of local, regional, and international PD experts convened to review the unmet needs of PD in Thailand and share insights into effective delivery of DAT, focusing on experience with apomorphine infusion. Despite its proven efficacy and safety, implementation of apomorphine infusion as a new option was not straightforward. This has prompted a range of health-care professional and patient-focused initiatives, led by the Chulalongkorn Center of Excellence for Parkinson’s Disease and Related Disorders in Bangkok, to help establish a more coordinated approach to PD management throughout the country and ensure patients have access to suitable treatments. Expert opinion: Overcoming the challenges of education, proficiency, resource capacity and standard of care for PD patients in developing countries requires a coordinated effort both nationally and beyond. The best practices identified in Thailand following the introduction of apomorphine infusion might be helpful for other countries when implementing similar programs.